Relevant bibliographies by topics / Radiobiological

Academic literature on the topic 'Radiobiological'

Author: Grafiati
Published: 4 June 2021
Last updated: 18 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Radiobiological.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Radiobiological"

1

Belmans, Niels, Anne Caroline Oenning, Benjamin Salmon, Bjorn Baselet, Kevin Tabury, Stéphane Lucas, Ivo Lambrichts, Marjan Moreels, Reinhilde Jacobs, and Sarah Baatout. "Radiobiological risks following dentomaxillofacial imaging: should we be concerned?" Dentomaxillofacial Radiology 50, no. 6 (September 1, 2021): 20210153. http://dx.doi.org/10.1259/dmfr.20210153.

Full text
Abstract:
Objectives: This review aimed to present studies that prospectively investigated biological effects in patients following diagnostic dentomaxillofacial radiology (DMFR). Methods: Literature was systematically searched to retrieve all studies assessing radiobiological effects of using X-ray imaging in the dentomaxillofacial area, with reference to radiobiological outcomes for other imaging modalities and fields. Results: There is a lot of variability in the reported radiobiological assessment methods and radiation dose measures, making comparisons of radiobiological studies challenging. Most radiological DMFR studies are focusing on genotoxicity and cytotoxicity, data for 2D dentomaxillofacial radiographs, albeit with some methodological weakness biasing the results. For CBCT, available evidence is limited and few studies include comparative data on both adults and children. Conclusions In the future, one will have to strive towards patient-specific measures by considering age, gender and other individual radiation sensitivity-related factors. Ultimately, future radioprotection strategies should build further on the concept of personalized medicine, with patient-specific optimization of the imaging protocol, based on radiobiological variables.
APA, Harvard, Vancouver, ISO, and other styles
2

Namdar, Aysan Mohammad, Mohammad Mohammadzadeh, Murat Okutan, and Asghar Mesbahi. "A review on the dosimetrical and radiobiological prediction of radiation-induced hypothyroidism in radiation therapy of head-and-neck cancer, breast cancer, and Hodgkin’s lymphoma survivors." Polish Journal of Medical Physics and Engineering 24, no. 4 (December 1, 2018): 137–48. http://dx.doi.org/10.2478/pjmpe-2018-0020.

Full text
Abstract:
Abstract A review on the radiobiological modeling of radiation-induced hypothyroidism after radiation therapy of head-and-neck cancers, breast cancer, and Hodgkin’s lymphoma is presented. The current review is based on data relating to dose-volume constrains and normal tissue complication probability (NTCP) as a function of either radiobiological or (pre)treatment-clinical parameters. Also, these data were explored in order to provide more helpful criteria for radiobiological optimization of treatment plans involving thyroid gland as a critical normal organ.
APA, Harvard, Vancouver, ISO, and other styles
3

Knaup, Courtney, Panayiotis Mavroidis, Gregory Swanson, Sotirios Stathakis, Dimos Baltas, and Niko Papanikolaou. "Inclusion of radiobiological factors in prostate brachytherapy treatment planning." Journal of Radiotherapy in Practice 12, no. 2 (June 28, 2012): 163–72. http://dx.doi.org/10.1017/s1460396912000209.

Full text
Abstract:
AbstractPurpose: Comparison of prostate seed implant treatment plans is currently based on evaluation of dose-volume histograms and doses to the tumour and normal structures. However, these do not account for effects of varying dose-rate, tumour repopulation and other biological effects. In this work, incorporation of the radiobiological response is used to obtain a more inclusive and clinically relevant treatment plan evaluation tool.Materials and Methods: Ten patients were evaluated. For each patient, six different treatment plans were created on the Prowess system. Plans with iodine-125 used a prescription dose of 145 Gy while plans with palladium-103 used 115 Gy. The biologically effective dose was used together with the tumour control probability and the normal tissue complication probabilities of urethra, bladder, rectum and surrounding tissue to evaluate the effectiveness of each treatment plan. Results from the radiobiological evaluation were compared to standard dose quantifiers.Results: The use of response probabilities is seen to provide a simpler means of treatment evaluation compared to standard dose quantifiers. This allows for different treatment plans to be quickly compared. Additionally, the use of radiobiologically-based plan evaluation allows for optimisation of seed type and initial seed strengths to find the ideal balance of TCP and NTCP.Conclusion: The goal of this work was to incorporate the biological response to obtain a more complete and clinically relevant treatment plan evaluation tool. This resulted in a simpler means of plan evaluation that may be used to compare and optimise prostate seed implant treatment plans.
APA, Harvard, Vancouver, ISO, and other styles
4

Santacroce, Antonio, Marcel A. Kamp, Wilfried Budach, and Daniel Hänggi. "Radiobiology of Radiosurgery for the Central Nervous System." BioMed Research International 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/362761.

Full text
Abstract:
According to Leksell radiosurgery is defined as “the delivery of a single, high dose of irradiation to a small and critically located intracranial volume through the intact skull.” Before its birth in the early 60s and its introduction in clinical therapeutic protocols in late the 80s dose application in radiation therapy of the brain for benign and malignant lesions was based on the administration of cumulative dose into a variable number of fractions. The rationale of dose fractionation is to lessen the risk of injury of normal tissue surrounding the target volume. Radiobiological studies of cell culture lines of malignant tumors and clinical experience with patients treated with conventional fractionated radiotherapy helped establishing this radiobiological principle. Radiosurgery provides a single high dose of radiation which translates into a specific toxic radiobiological response. Radiobiological investigations to study the effect of high dose focused radiation on the central nervous system began in late the 50s. It is well known currently that radiobiological principles applied for dose fractionation are not reproducible when single high dose of ionizing radiation is delivered. A review of the literature about radiobiology of radiosurgery for the central nervous system is presented.
APA, Harvard, Vancouver, ISO, and other styles
5

Birschwilks, M., M. Gruenberger, C. Adelmann, S. Tapio, G. Gerber, P. N. Schofield, and B. Grosche. "The European Radiobiological Archives: Online Access to Data from Radiobiological Experiments." Radiation Research 175, no. 4 (April 2011): 526–31. http://dx.doi.org/10.1667/rr2471.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Knaup, Courtney, Panayiotis Mavroidis, Carlos Esquivel, Sotirios Stathakis, Gregory Swanson, Dimos Baltas, and Nikos Papanikolaou. "Radiobiological comparison of single and dual-isotope prostate seed implants." Journal of Radiotherapy in Practice 12, no. 2 (August 2, 2012): 154–62. http://dx.doi.org/10.1017/s1460396912000076.

Full text
Abstract:
AbstractPurpose: Several isotopes are available for low dose-rate prostate brachytherapy. Currently most implants use a single isotope. However, the use of dual-isotope implants may yield an advantageous combination of characteristics such as half-life and relative biological effectiveness. However, the use of dual-isotope implants complicates treatment planning and quality assurance. Do the benefits of dual-isotope implants outweigh the added difficulty? The goal of this work was to use a linear-quadratic model to compare single and dual-isotope implants.Materials & Methods: Ten patients were evaluated. For each patient, six treatment plans were created with single or dual-isotope combinations of 125I, 103Pd and 131Cs. For each plan the prostate, urethra, rectum and bladder were contoured by a physician. The biologically effective dose was used to determine the tumor control probability and normal tissue complication probabilities for each plan. Each plan was evaluated using favorable, intermediate and unfavorable radiobiological parameters. The results of the radiobiological analysis were used to compare the single and dual-isotope treatment plans.Results: Iodine-125 only implants were seen to be most affected by changes in tumor parameters. Significant differences in organ response probabilities were seen at common dose levels. However, after adjusting the initial seed strength the differences between isotope combinations were minimal.Conclusions: The objective of this work was to perform a radiobiologically based comparison of single and dual-isotope prostate seed implant plans. For all isotope combinations, the plans were improved by varying the initial seed strength. For the optimized treatment plans, no substantial differences in predicted treatment outcomes were seen among the different isotope combinations.
APA, Harvard, Vancouver, ISO, and other styles
7

Birschwilks, M., P. N. Schofield, and B. Grosche. "The European Radiobiological Archives." Health Physics 102, no. 2 (February 2012): 220. http://dx.doi.org/10.1097/hp.0b013e3182216d02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Nahum, A. E. "243 Radiobiological treatment planning." Radiotherapy and Oncology 76 (September 2005): S117. http://dx.doi.org/10.1016/s0167-8140(05)81220-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Goldman, M. "Chernobyl: a radiobiological perspective." Science 238, no. 4827 (October 30, 1987): 622–23. http://dx.doi.org/10.1126/science.3672115.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schimmerling, Walter. "Radiobiological problems in space." Radiation and Environmental Biophysics 31, no. 3 (September 1992): 197–203. http://dx.doi.org/10.1007/bf01214827.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Radiobiological"

1

Hollis, Kevin John. "Microbeam design in radiobiological research." Thesis, Brunel University, 1995. http://bura.brunel.ac.uk/handle/2438/4824.

Full text
Abstract:
Recent work using low-doses of ionising radiations, both in vitro and in ViVO, has suggested that the responses of biological systems in the region of less than 1 Gray may not be predicted by simple extrapolation from the responses at higher doses. Additional experiments, using high-LET radiations at doses of much less than one alpha particle traversal per cell nucleus, have shown responses in a greater number of cells than have received a radiation dose. These findings, and increased concern over the effects of the exposure of the general population to low-levels of background radiation, for example due to radon daughters in the lungs, have stimulated the investigation of the response of mammalian cells to ionising radiations in the extreme low-dose region. In all broad field exposures to particulate radiations at low-dose levels an inherent dose uncertainty exists due to random counting statistics. This dose variation produces a range of values for the measured biological effect within the irradiated population, therefore making the elucidation of the dose-effect relationship extremely difficult. The use of the microbeam irradiation technique will allow the delivery of a controlled number of particles to specific targets within an individual cell with a high degree of accuracy. This approach will considerably reduce the level of variation of biological effect within the irradiated cell population and will allow low-dose responses of cellular systems to be determined. In addition, the proposed high spatial resolution of the microbeam developed will allow the investigation of the distribution of radiation sensitivity within the cell, to provide a better understanding of the mechanisms of radiation action. The target parameters for the microbeam at the Gray Laboratory are a spatial resolution of less than 1 urn and a detection efficiency of better than 99 %. The work of this thesis was to develop a method of collimation, in order to produce a microbeam of 3.5 MeV protons, and to develop a detector to be used in conjunction with the collimation system. In order to determine the optimum design of collimator necessary to produce a proton microbeam, a computer simulation based upon a Monte-Carlo simulation code, written by Dr S J Watts, was developed. This programme was then used to determine the optimum collimator length and the effects of misalignment and divergence of the incident proton beam upon the quality of the collimated beam produced. Designs for silicon collimators were produced, based upon the results of these simulations, and collimators were subsequently produced for us using techniques of micro-manufacturing developed in the semiconductor industry. Other collimator designs were also produced both in-house and commercially, using a range of materials. These collimators were tested to determine both the energy and spatial resolutions of the transmitted proton beam produced. The best results were obtained using 1.6 mm lengths of 1.5 µm diameter bore fused silica tubing. This system produced a collimated beam having a spatial resolution with 90 % of the transmitted beam lying within a diameter of 2.3 ± 0.9 µm and with an energy spectrum having 75 % of the transmitted protons within a Gaussian fit to the full-energy peak. Detection of the transmitted protons was achieved by the use of a scintillation transmission detector mounted over the exit aperture of the collimator. An approximately 10 urn thick ZnS(Ag) crystal was mounted between two 30 urn diameter optical fibres and the light emitted from the crystal transmitted along the fibres to two photomultiplier tubes. The signals from the tubes were analyzed, using coincidence counting techniques, by means of electronics designed by Dr B Vojnovic. The lowest counting inefficiencies obtained using this approach were a false positive count level of 0.8 ± 0.1 % and an uncounted proton level of 0.9 ± 0.3 %. The elements of collimation and detection were then combined in a rugged microbeam assembly, using a fused silica collimator having a bore diameter of 5 urn and a scintillator crystal having a thickness of - 15 µm. The microbeam produced by this initial assembly had a spatial resolution with 90 % of the transmitted protons lying within a diameter of 5.8 ± 1.6 µm, and counting inefficiencies of 0.27 ± 0.22 % and 1.7 ± 0.4 % for the levels of false positive and missed counts respectively. The detector system in this assembly achieves the design parameter of 99 % efficiency, however, the spatial resolution of the beam is not at the desired I urn level. The diameter of the microbeam beam produced is less than the nuclear diameter of many cell lines and so the beam may be used to good effect in the low-dose irradiation of single cells. In order to investigate the variation in sensitivity within a cell the spatial resolution of the beam would require improvement. Proposed methods by which this may be achieved are described.
APA, Harvard, Vancouver, ISO, and other styles
2

Coghill, Matthew Taylor. "Radiobiological modeling using track structure analysis." Thesis, Georgia Institute of Technology, 2012. http://hdl.handle.net/1853/44731.

Full text
Abstract:
The purpose of this thesis is to present data pertinent to and propose conclusions regarding the coordination of radiobiologic effectiveness (RBE) and linear energy transfer (LET). RBE is a quantity relating the effectiveness of different radiations in causing cell death. LET is a measure of the rate of energy transferred to material by an ionizing particle. This relationship of these values varies for different particles. The reason for this is still inconclusive. The petitioner has made use of a toolkit for Geant4, known as Geant4-DNA, to perform track-structure analysis on a chromosome model. Geant4 is an object-oriented program for the "simulation of the passage of particles through matter" developed by CERN that makes use of Monte Carlo methods and is expanded by Geant4-DNA to handle low-energy electron physics as well as physic-chemical effects. The chromosome model, in this case, has been developed by the petitioner as a nucleus with a basic, uniform distribution of chromatin. Radiation damage to DNA, in the form of aberrations, lesions and strand breaks, can be coordinated to energy deposited or number of ionizations occurring in the target (in this case DNA or chromatin fiber). Certain threshold values have been established as indicate of different types of DNA damage. The ultimate goal of this work is to score these clusters of events against the threshold values to determine the severity of DNA damage. The final comparison of the results for different particles will provide for a better understanding of the RBE-LET relationships by improving the understanding of the underlying nanodosimetric qualities.
APA, Harvard, Vancouver, ISO, and other styles
3

Weeks, Amanda. "Radiobiological Effects of internalised Radiopharmaceuticals in Human Cells." Thesis, University of Kent, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.499642.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sandström, Helena. "Contouring variability in radiosurgery - dosimetric and radiobiological implications." Licentiate thesis, Stockholms universitet, Fysikum, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-123252.

Full text
Abstract:
The use of Stereotactic Radiation Therapy (SRT) employing one large fraction of radiation, as in stereotactic radiosurgery (SRS), or few fractions of high doses, has continuously increased due to the technical development and the progress in dose delivery complemented by the positive clinical experience. The success of stereotactic radiation therapy depends on many clinical, dosimetric and radiobiological factors. For SRS in particular, the delivery of a highly conformal dose distribution to the target in one fraction allowing at the same time the sparing of the normal tissue and the critical structures is part of the basic concept of the technique. Provided that the highly accurate radiosurgical equipment available today is used, planning and delivering the prescribed dose distribution is an achievable goal, and therefore the main issue to be solved is the definition of the target. As the target volume in radiosurgery is usually defined without margins, the success of the stereotactic approach critically depends on the accurate delineation of the target which could be identified as a factor of key importance. In addition, the delineation of the Organs At Risk (OAR) is also critical. The purpose of this work was to evaluate the current degree of variability for target and OAR contouring and to establish methods for analysing multi-observer data regarding structure delineation variability. A multi-center target and OAR delineation study was initiated. Two complex and six common cases to be treated with SRS were selected and subsequently distributed to centers around the world performing Gamma Knife® radiosurgery for delineation and treatment planning. The resulting treatment plans and the corresponding delineated structures were collected and analysed.    Results showed a very high variability in contouring for four complex radiosurgery targets. Similar results indicating high variability in delineating the OAR and reporting the doses delivered to them were also reported. For the common radiosurgery targets however, a higher agreement in the delineation was observed, although lower than expected. The assessment of the quality of treatment planning for radiosurgery is usually performed with respect to the coverage of the target, the planning specificity, and dose to the sensitive structures and organs close to the target. However, physical dose conformity to the target does not guarantee the success of the treatment. The assessment of the plan quality should also be performed with respect to the clinical outcome expressed as probability of controlling the target that should be irradiated. In this respect, this study also aimed to create the framework for assessing the impact of the inaccuracy in delineating the target on the predicted treatment outcome for radiosurgery targets known for their high potential to invade the neighbouring normal tissue, using radiobiological models. In addition, radiobiological models have also been used to determine the tumour control probability accounting for the oxygenation for stereotactic radiation therapy targets. The results suggest that radiobiological modelling has the potential to add to the current knowledge in SRS by theoretically assessing the key factors that might influence the treatment outcome.
APA, Harvard, Vancouver, ISO, and other styles
5

Bertrand, Olivier F. "Prevention of coronary restenosis using a radioactive stent : radiobiological studies." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp03/NQ64515.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Falk, Jennie. "Robust Optimization for Uncertain Radiobiological Parameters in Inverse Dose Planning." Thesis, KTH, Optimeringslära och systemteori, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-160135.

Full text
Abstract:
Cancer is a common cause of death worldwide with radiotherapy as one of the most used treatments. Radiation treatment plans are normally optimized using constraints on the maximum dose to tumours and minimum dose to surrounding healthy structures. It has been suggested that utilizing biological models in the radiation plan optimization process could improve outcome significantly. Such treatment plans depend not only on the accuracy of the biological models, describing the dose response relations of different tumours and other structures, but also on the accuracy of tissue specific parameters in these models. Different sets of biological model parameters lead to different treatment plans and thus, uncertainties in these parameters may compromise the quality of the treatments. In this thesis, several radiobiological optimization models have been developed, including either the concepts of Tumour Control Probability (TCP) and Normal Tissue Complication Probability (NTCP), or Equivalent Uniform Dose (EUD). The uncertainties of model parameters are expressed by probability density functions included in the dose optimization process. Robust optimization methods that account for the uncertainties have been developed and implemented in a MATLAB GUI created for Gamma Knife surgery. The robust optimized dose plans have been compared to non-robust plans using fixed parameter values. The results suggest that the final dose distribution strongly depend on the distribution functions and that the robust treatment plans are less dependent on variations in the model parameters
Cancer är en av de största dödsorsakerna i världen idag, och strålningsterapi är en vanligt förekommande behandlingsform. Vanligtvis optimeras behandlingsplaner för strålningsbehandlingar genom att sätta villkor på en minimal dos till tumörer och en maximal dos till omkringliggande vävnad. Biologiska modeller har utvecklats som ett alternativ till dessa villkor, för att användas i optimeringen av behandlingsplaner. Resultatet av sådan radiobiologisk dosoptimering beror inte endast av kvaliteten på de biologiska modellerna, utan även på noggrannheten i de vävnadsspecifika parametrar som finns i modellerna. Olika val av parametervärden leder till olika resultat och därför kommer osäkerheter i dessa parametrar att äventyra kvaliteten på strålningsbehandlingar. Radiobiologiska optimeringsmodeller som inkluderar koncepten Tumour Control Probability (TCP) och Normal Tissue Complication Probability (NTCP), eller Equivalent Uniform Dose (EUD) har utvecklats i detta examensarbete. De osäkra modellparametrar har uttryckts med sannolikhetsfördelningar och inkluderats i optimeringsmodellen. Robusta optimeringsmetoder som tar hänsyn till osäkerheter har utvecklats och implementerats i ett grafiskt användargrässnitt i MATLAB, med syftet att kunna användas i Gammaknivs- kirurgi. De optimerade robusta dosplanerna har jämförts med icke-robusta optimerade dosplaner där värden på de osäkra parametrarna är konstanta. Resultaten pekar på att dosplanerna starkt beror på de olika fördelningar av parametrar som använts och att robusta optimeringsmetoder ger behandlingsplaner som är mindre känsliga för variationer i de biologiska parametrarna.
APA, Harvard, Vancouver, ISO, and other styles
7

Mavroidis, Panayiotis. "Determination and use of radiobiological response parameters in radiation therapy optimization /." Stockholm : Karolinska Univ. Press, 2001. http://diss.kib.ki.se/2001/91-7349-092-X/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Iori, Mauro. "Rotational intensity modulated radiation therapy : dosimetric, treatment planning, and radiobiological aspects." Thesis, University of Liverpool, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.569581.

Full text
Abstract:
The introduction in Radiation Oncology of x-ray beams fluence modulation, the treatment technique known as Intensity Modulated Radiation Therapy (IMRT), is leading to the flourishing of new and increasingly sophisticated treatments. It is within this context that delivery systems have been evolving from static to rotational IMRT techniques through which significant advantages have occurred in terms of treatment plan quality, delivery efficiency and accuracy, although paying the price of longer calculation times for the plan optimization. The point has been reached where the perceived advantages of rotational IMRT techniques, for which some companies have marketed therapy systems with different architecture from that of conventional linear accelerators, have led users to question whether the established and more conventional systems are becoming obsolete. However, the newly available methods of delivering Intensity Modulated Arc Therapies (IMAT) using conventional accelerators, an advanced form of rotational IMRT that combines multiple arcs with variable fluence and gantry speed, seem to have provided a preliminary answer to this concern. Although it is difficult to know which of these treatment modalities will be discontinued in the near future, it is clear that the rotational IMR T is expected to become increasingly important. Therefore, the problem of understanding which are the strengths of these techniques, or the most effective methods (forward or inverse-planning based) of their treatment planning procedures, as well as the most robust and effective systems for verifying dosimetrically such rotational deliveries can be considered current research topics. As a results, different aspects of rotational IMRT techniques have been investigated in this work, starting with the pre-clinical dosimetry of IMAT therapies, passing through the planning procedures also in comparison with static IMR T, and advancing to a special application of 'rotational IMRT': the simulation of radiobiologically optimised, voxel-based dose-painting, guided by the metabolic tumour imaging. In particular we have worked on: two methods for the pre-clinical dosimetry of IMA T treatments using a matrix detector of ionization-chambers and an electronic portal imaging device, a forward and an inverse-planning approach for simulating IMAT treatments, a ranking of plans simulated with static and rotational IMRT modalities on prostate tumour. The high conformality achievable by rotational IMRT, as well as its potential to deliver selectively different doses inside a heterogeneous target volume, together with the image guidance capabilities of the newest therapy units, makes arc modulation the most appropriate and suitable instrument for assessing future "dose painting" treatments. In this regard, two radiobiological objective functions for guiding the dose redistribution inside a group of prostate tumours according to their estimated clonogenic density distribution (based on Position Emission Tomography imaging) were developed, compared and analysed.
APA, Harvard, Vancouver, ISO, and other styles
9

Fernandez, Alejandro Carabe. "A theoretical investigation of the radiobiological rationale for high-LET radiotherapy." Thesis, Imperial College London, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.487551.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Conere, Thomas James. "The radiobiological effects of gas mixtures under ambient and hyperbaric conditions." Thesis, Queen's University Belfast, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.292290.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Radiobiological"

1

Dale, Roger G., and Bleddyn Jones, eds. Radiobiological Modelling in Radiation Oncology. 48–50 St John Street, London EC1M 4DG, UK: The British Institute of Radiology, 2007. http://dx.doi.org/10.1259/9780905749839.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Awwad, Hassan K. Radiation Oncology: Radiobiological and Physiological Perspectives. Dordrecht: Springer Netherlands, 1990. http://dx.doi.org/10.1007/978-94-015-7865-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wilson, John W. Preliminary analysis of a radiobiological experiment for LifeSat. Hampton, Va: Langley Research Center, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Anderson, S. L. Effects of radiation on aquatic organisms and radiobiological methodologies for effects assessment. Washington, D.C: U.S. Environmental Protection Agency, Office of Radiation Programs, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Anderson, S. L. Effects of radiation on aquatic organisms and radiobiological methodologies for effects assessment. Washington, D.C: U.S. Environmental Protection Agency, Office of Radiation Programs, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Anderson, S. L. Effects of radiation on aquatic organisms and radiobiological methodologies for effects assessment. Washington, D.C: U.S. Environmental Protection Agency, Office of Radiation Programs, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

W, Wilson John. Effects of radiobiological uncertainty on shield design for a 60-day lunar mission. Hampton, Va: Langley Research Center, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wilson, John W. Effects of radiobiological uncertainty on shield design for a 60-day lunar mission. [Washington, DC]: National Aeronautics and Space Administration, Office of Management, Scientific and Technical Information Program, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

W, Wilson John. Effects of radiobiological uncertainty on vehicle and habitat shield design for missions to the Moon and Mars. Hampton, Va: Langley Research Center, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Burlakova, E. B. The effects of low dose radiation: New aspects of radiobiological research prompted by the Chernobyl nuclear disaster. Utrecht: VSP, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Radiobiological"

1

Trott, Klaus-Rüdiger, Friedrich-Hugo Kamprad, and Guido Hildebrandt. "Radiobiological Principles." In Radiotherapy for Non-Malignant Disorders, 3–27. Berlin, Heidelberg: Springer Berlin Heidelberg, 2008. http://dx.doi.org/10.1007/978-3-540-68943-0_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mukherji, Ashutosh. "Radiobiological Principles." In Basics of Planning and Management of Patients during Radiation Therapy, 49–59. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-6659-7_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Olivos III, David J., Rajendran Sellamuthu, Pratibha Singh, Sasidhar Vemula, Louis M. Pelus, Christie M. Orschell, and Melissa A. Kacena. "Stem Cell Niche-Radiobiological Response." In Stem Cell Biology and Regenerative Medicine, 129–46. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-21702-4_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dale, R. G. "Radiobiological Considerations in Gynaecological Radiotherapy." In Radiation Oncology of Gynecological Cancers, 13–23. Berlin, Heidelberg: Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-60334-1_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Scoccianti, Silvia, Riccardo Santoni, Beatrice Detti, Gianluca Ingrosso, Daniela Greto, and Giulio Francolini. "Radiobiological Hints from Clinical Studies." In Current Clinical Pathology, 29–40. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-28305-0_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pedicini, Piernicola, Lidia Strigari, Luigi Spiazzi, Alba Fiorentino, Paolo Tini, and Luigi Pirtoli. "Mathematical Modelling of Radiobiological Parameters." In Current Clinical Pathology, 87–100. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-28305-0_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Stewart, R. D., and R. J. Traub. "Radiobiological Modeling in Voxel Constructs." In Advanced Monte Carlo for Radiation Physics, Particle Transport Simulation and Applications, 285–90. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-18211-2_45.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dale, Roger G., and Judith A. Sinclair. "9 Radiobiological calculations in routine radiotherapy." In Radiobiological Modelling in Radiation Oncology, 158–68. 48–50 St John Street, London EC1M 4DG, UK: The British Institute of Radiology, 2007. http://dx.doi.org/10.1259/9780905749839.chapter09.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Jones, Bleddyn, and Roger G. Dale. "Mathematical Appendix." In Radiobiological Modelling in Radiation Oncology, 276–83. 48–50 St John Street, London EC1M 4DG, UK: The British Institute of Radiology, 2007. http://dx.doi.org/10.1259/9780905749839.appendix.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Jones, Bleddyn, and Roger G. Dale. "1 The discipline of mathematical modelling." In Radiobiological Modelling in Radiation Oncology, 1–11. 48–50 St John Street, London EC1M 4DG, UK: The British Institute of Radiology, 2007. http://dx.doi.org/10.1259/9780905749839.chapter01.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Radiobiological"

1

Policroniades, Rafael, A. Varela, J. Guzman, and U. Graaf. "Neutron facility for radiobiological studies." In Fifth International Conference on Applications of Nuclear Techniques: Neutrons in Research and Industry, edited by George Vourvopoulos. SPIE, 1997. http://dx.doi.org/10.1117/12.267936.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Yogo, A., K. Sato, M. Nishikino, M. Mori, T. Teshima, H. Numasaki, M. Murakami, et al. "Radiobiological study by using laser-driven proton beams." In LASER-DRIVEN RELATIVISTIC PLASMAS APPLIED TO SCIENCE, INDUSTRY AND MEDICINE: 2nd International Symposium. AIP, 2009. http://dx.doi.org/10.1063/1.3204555.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Szefliński, Zygmunt, Mateusz Filipek, Jakub Gotlib, and Urszula Kaźmierczak. "RADIOBIOLOGICAL RESEARCH AND DOSIMETRY USING A FLAT ALPHA SOURCE." In RAP Conference. Sievert Association, 2020. http://dx.doi.org/10.37392/rapproc.2019.02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Schramm, U., K. Zeil, C. Richter, E. Beyreuther, M. Bussmann, T. E. Cowan, W. Enghardt, et al. "Ultrashort Pulse Laser Accelerated Proton Beams for First Radiobiological Applications." In ADVANCED ACCELERATOR CONCEPTS: 14th Advanced Accelerator Concepts Workshop. AIP, 2010. http://dx.doi.org/10.1063/1.3520421.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Obst-Huebl, Lieselotte, Jianhui Bin, Jian-Hua Mao, Laura Geulig, Hang Chang, Kei Nakamura, Qing Ji, et al. "Radiobiological studies with laser-driven protons at the BELLA PW." In Applying Laser-driven Particle Acceleration II, Medical and Nonmedical Uses of Distinctive Energetic Particle and Photon Sources: SPIE Optics + Optoelectronics Industry Event, edited by Paul R. Bolton. SPIE, 2021. http://dx.doi.org/10.1117/12.2596505.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Nishikino, Masaharu, Katsutoshi Sato, Shinsuke Ohshima, Noboru Hasegawa, Masahiko Ishino, Tetsuya Kawachi, Yasuaki Okano, Hodaka Numasaki, Teruki Teshima, and Hiroaki Nishimura. "Development of focused laser plasma x-ray beam for radiobiological applications." In The Pacific Rim Conference on Lasers and Electro-Optics (CLEO/PACIFIC RIM). IEEE, 2009. http://dx.doi.org/10.1109/cleopr.2009.5292124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Satoh, Daisuke, Naoki Ikeda, Mitsuhiro Yoshida, and Mitsuru Uesaka. "A photoconductive semiconductor switch driven ion beam injector for radiobiological experiments." In Proceedings of the 17th International Conference on Ion Sources. Author(s), 2018. http://dx.doi.org/10.1063/1.5053397.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ojeda, Abril Damaris Iglesias, Monserrat Llaguno Munive, Efrén Hernández Ramirez, and Luis Alberto Medina Velázquez. "Dosimetry in fractionated irradiation of rat brain to evaluate radiobiological response." In PROCEEDINGS OF THE XVI MEXICAN SYMPOSIUM ON MEDICAL PHYSICS. AIP Publishing, 2021. http://dx.doi.org/10.1063/5.0051374.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kato, Takamitsu, Akihisa Tsuda, Akira Fujimori, Tadashi Kamada, Hirohiko Tsujii, and Ryuichi Okayasu. "Abstract 504: First in vitro radiobiological characterizations of cells from chordoma origin." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Herrera, Higmar, Elvia Yañez, and Jesús López. "Radiobiological compensation: A case study of uterine cervix cancer with concurrent chemotherapy." In MEDICAL PHYSICS: Twelfth Mexican Symposium on Medical Physics. AIP, 2012. http://dx.doi.org/10.1063/1.4764590.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Radiobiological"

1

Potter, Charles Augustus, Susan W. Longley, Bobby R. Scott, Yong Lin, Julie Wilder, Julie A. Hutt, Mabel T. Padilla, and Katherine M. Gott. Radiobiological studies using gamma and x rays. Office of Scientific and Technical Information (OSTI), February 2013. http://dx.doi.org/10.2172/1093692.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hopewell, J. W., G. M. Morris, and J. A. Coderre. Determination of radiobiological parameters for the safe clinical application of BNCT. Office of Scientific and Technical Information (OSTI), December 1993. http://dx.doi.org/10.2172/10136300.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lin, Yong, Bobby Scott, Bryanna Saxton, Wenshu Chen, Steven Belinsky, and Charles Potter. Radiobiological Studies Using Cs-137 Gamma or 320 kV X Rays. Office of Scientific and Technical Information (OSTI), December 2020. http://dx.doi.org/10.2172/1738884.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hei, Tom K. The Radiobiological Basis for Improvements in Radiotherapy and Low Dose Risk Assessment. Office of Scientific and Technical Information (OSTI), December 2009. http://dx.doi.org/10.2172/968636.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

George Sgouros, Ph D. Patient-Specific Dosimetry and Radiobiological Modeling of Targeted Radionuclide Therapy Grant - final report. Office of Scientific and Technical Information (OSTI), March 2007. http://dx.doi.org/10.2172/901074.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Radiobiological' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography